Faculty
-
August 30, 2016
Robert Klitzman on EpiPen's Price Hike
With EpiPen price-gouging in the news, Columbia's School of Professional Studies Bioethics Program Director, Dr. Robert Klitzman, has a new op-ed in CNN about the ethical questions raised by drug companies' overcharging patients. It's a tangled story of the principles of medicine, the profit priorities of private companies, and the taxpayers' money that creates these innovations.
Read the full article at CNN.
Faculty, In the Media
Kiran Bhujle, Global Managing Director at SVAM International and part-time lecturer in M.S. in Enterprise Risk Management and M.S. Technology Management programs, explores how AI is reshaping who gets to build technology.
(Forbes)
Faculty
In Columbia’s Nonprofit Management program, lecturers Ramone Segree and John Hicks share real-world insights on building impactful careers in today’s evolving nonprofit sector.
Faculty
Cuts to the U.S. Forest Service weaken science, staffing, and oversight, leaving forests more vulnerable to harm and misuse.
All News
